AOD 9604 demonstrated a strong safety profile across more than 900 participants in Phase II human trials, with no serious adverse events reported and generally mild, well-tolerated side effects [3]
No evidence-based guidelines regarding the use of B 12 testing in people with suspected B 12 deficiency
The most common side effects include: Injection site reactions: It is common to experience mild redness, swelling, or itching on the injection site
Here are six of the peptide-prescribing doctors and clinic heads who stand to potentially win more business from their decisions: Gabriel Alizaidy Title: Scientific Director of Maximus Health, a telehealth company offering peptides Who he is: Alizaidy calls himself a "peptide and hormone researcher, educator, and advisor." According to LinkedIn, he went to medical school in Pakistan and did a master's in precision health at the University of Chicago
So, is it necessary to take supplements, or is there enough B12 vitamins in your diet
What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects
